Koers Integrative Health Technologies, Inc. Other OTC
Aandelen
IHTI
US45822A2078
Biotechnologie & Medisch Onderzoek
Omzet 2008 | 0,43 0,4 | Omzet 2009 | 0,45 0,41 | Marktkapitalisatie | 1,22 mln. 1,12 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2008 | - 0 | Nettowinst (verlies) 2009 | - 0 | EV/omzet 2008 | 14.379.727 x |
Nettoschuld 2008 | 99,02K 91,07K | Nettoschuld 2009 | 94,3K 86,72K | EV/omzet 2009 | 2.939.517 x |
K/w-verhouding 2008 |
231
x | K/w-verhouding 2009 |
31,6
x | Werknemers | - |
Dividendrendement 2008 * |
-
| Dividendrendement 2009 |
-
| Vrij verhandelbaar | 48,33% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Gilbert R. Kaats
CEO | Chief Executive Officer | - | - |
Samuel C. Keith
CIO | Chief Investment Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Gilbert R. Kaats
CEO | Chief Executive Officer | - | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+29,77% | 49,46 mld. | |
+1,00% | 42,58 mld. | |
+49,62% | 42,49 mld. | |
-5,26% | 29,09 mld. | |
+13,68% | 26,61 mld. | |
-22,99% | 18,64 mld. | |
+8,22% | 13,16 mld. | |
+32,41% | 12,55 mld. | |
+24,01% | 12,1 mld. |